CCDC115-CDG: A new rare and misleading inherited cause of liver disease

Archive ouverte

Girard, Muriel | Poujois, Aurélia | Fabre, Monique | Lacaille, Florence | Debray, Dominique | Rio, Marlène | Fenaille, François | Cholet, Sophie | Ruel, Coralie | Caussé, Elizabeth | Selves, Janick | Bridoux-Henno, Laure | Woimant, France | Dupré, Thierry | Vuillaumier-Barrot, Sandrine | Séta, Nathalie | Alric, Laurent | de Lonlay, Pascale | Bruneel, Arnaud

Edité par CCSD ; Elsevier -

International audience. Congenital disorders of glycosylation (CDG) linked to defects in Golgi apparatus homeostasis constitute an increasing part of these rare inherited diseases. Among them, COG-CDG, ATP6V0A2-CDG, TMEM199-CDG and CCDC115-CDG have been shown to disturb Golgi vesicular trafficking and/or lumen pH acidification. Here, we report 3 new unrelated cases of CCDC115-CDG with emphasis on diagnosis difficulties related to strong phenotypic similarities with mitochondriopathies, Niemann-Pick disease C and Wilson Disease. Indeed, while two individuals clinically presented with early and severe liver fibrosis and cirrhosis associated with neurological symptoms, the other one "only" showed isolated and late severe liver involvement. Biological results were similar to previously described patients, including hypercholesterolemia, elevated alkaline phosphatases and defects in copper metabolism. CDG screening and glycosylation study finally led to the molecular diagnosis of CCDC115-CDG. Besides pointing to the importance of CDG screening in patients with unexplained and severe liver disease, these reports expand the clinical and molecular phenotypes of CCDC115-CDG. The hepatic involvement is particularly addressed. Furthermore, hypothesis concerning the pathogenesis of the liver disease and of major biological abnormalities are proposed.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion